Death in ILD - Why arent we talking about it?

A. Hudson (London, United Kingdom), A. Hare (London, United Kingdom), L. Berry (London, United Kingdom), L. Freeman (London, United Kingdom), P. George (London, United Kingdom)

Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new?
Disease area: -

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Hudson (London, United Kingdom), A. Hare (London, United Kingdom), L. Berry (London, United Kingdom), L. Freeman (London, United Kingdom), P. George (London, United Kingdom). Death in ILD - Why arent we talking about it?. 5186

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Can we diagnose ILD ? - Yes, we can! Interactive cases
Source: ERS Courses: Interstitial Lung Diseases
Year: 2019


Can we diagnose ILD ? - Yes, we can! Interactive cases
Source: ERS Course 2019 - Interstitial Lung Diseases
Year: 2019


"Don’t get me wrong, I think case finding is okay" Exploring healthcare professionals’ perspectives on target case-finding for COPD
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016

Respiratory disease in the community. Who‘s got what?
Source: Annual Congress 2009 - Diagnostic strategies in primary respiratory care
Year: 2009


Mesothelioma - no longer a hopeless disease!
Source: Annual Congress 2008 - Malignant pleural mesothelioma: new aspects in treatment and aetiology
Year: 2008


What's in a name? That which we call IPF, by any other name would act the same
Source: Eur Respir J, 51 (5) 1800692; 10.1183/13993003.00692-2018
Year: 2018



Prognosis in COPD. Ignorance is bliss?
Source: Eur Respir J 2002; 20: Suppl. 38, 264s
Year: 2002

Who's (still) afraid of talc?
Source: Eur Respir J 2007; 29: 619-621
Year: 2007


Clustering in asthma: why, how and for how long?
Source: Eur Respir J 2013; 41: 1247-1248
Year: 2013


Troubleshooting - what to do when NIV is not going well?
Source: School Course 2014 - Noninvasive ventilation: basic concepts
Year: 2014


How can we stop people with COPD dying?
Source: Annual Congress 2006 - New insights into the worldwide burden of COPD
Year: 2006


Why isn't his asthma getting better Doctor?
Source: ERS Live 2009
Year: 2009


CPAP and me: what's wrong?
Source: Virtual Congress 2020 – Pathophysiology and treatment of obstructive sleep apnoea
Year: 2020


Do not attempt resuscitation decisions (DNACPR): Do we fulfil the human rights act?
Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases
Year: 2016


Breathlessness: respiratory, cardiac, or something else?
Source: International Congress 2015 – Primary Care Programme
Year: 2015



Monitoring at home - telemedicine, how and why?
Source: Annual Congress 2004 - PG21 - Home mechanical ventilation in COPD patients
Year: 2004


Who, where, how and why smokes in high school? Who cares about them?
Source: Eur Respir J 2004; 24: Suppl. 48, 609s
Year: 2004

Influenza news from the frontline: what's happening?
Source: ERJ Open Res, 4 (1) 00020-2018; 10.1183/23120541.00020-2018
Year: 2018